Levothyroxine Sodium Tablets USP 150 mcg Recall: Subpotent
Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Princeton, NJ, Manufactured by…
What is the FDA recall status?
The FDA record lists this recall as ongoing. FDA enforcement data is not a live recall-lifecycle tracker. Follow the official instructions and check the agency notice or firm for current guidance.
Why was Levothyroxine Sodium Tablets USP 150 mcg recalled?
Subpotent Drug
What should I do if I have this product?
Follow the firm and FDA instructions for the affected product. Contact the recalling firm for current guidance.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare your product with the product description and available lot, UPC or model codes below from the official FDA record to check whether it is covered by this recall. If an identifier is missing or unclear, check the complete official notice or contact the firm; an incomplete match here does not establish that your product is unaffected.
Full product description
Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Princeton, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Sarigam, Valsad, Guajarat, INDIA NDC 33342-401-44
Which lot codes, UPCs or models are affected?
Lot 16240062A, exp date 3/2026
- Agency record number
- D-0403-2026
- Product
- Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Princeton, NJ, Manufactured by…
- Recalling firm
- MACLEODS PHARMA USA, INC
- Quantity
- 1315 bottles
- Distribution
- Nationwide
- Recall started
- February 26, 2026
- Report date
- April 1, 2026
- Classification
- Class II
- Status
- Ongoing
- Agency
- FDA (drug)